Navan Accelerates NDC Adoption with New Emirates Partnership
Direct integration gives Navan customers access to exclusive Emirates fares and premium travel options PALO ALTO, Calif.–(BUSINESS WIRE)–Navan (NASDAQ:... Read more.
Karooooo to Announce Third Quarter 2026 Results on January 20, 2026
SINGAPORE–(BUSINESS WIRE)–Karooooo Limited (NASDAQ: KARO) (“Karooooo” or “the Company”), which owns 100% of Cartrack and 81% of Karooooo Logistics,... Read more.
Cast AI Valued at Over $1 Billion With the Launch of Its GPU Marketplace
OMNI Compute is a unified compute marketplace that enables enterprises to access, provision, and operate GPUs across any cloud or region, with no code changes required... Read more.
Kopin to Participate in the 28th Annual Needham Growth Conference on January 16, 2026
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin Corporation (NASDAQ: KOPN) a leading provider of application-specific optical systems and high-performance microdisplays... Read more.
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve... Read more.
Algolia Collaborates with Microsoft to Drive Real-Time Product Data to Shopping Experiences
Collaboration gives retailers fresher visibility, increased discoverability, and new influence across AI-powered shopping channels SAN FRANCISCO–(BUSINESS... Read more.
Mirador Accelerates Multi-Asset Clinical Pipeline in Immuno-Fibrotic Disease; Closes $250 Million Series B with Premier Investors
Advancing multiple programs across Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and idiopathic pulmonary fibrosis; 10+ clinical readouts expected... Read more.
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
Strategic collaboration expands taletrectinib global reach with a leading oncology partner Eisai will receive exclusive development, registration and commercialization... Read more.
MakeMyTrip Limited to Report Fiscal 2026 Third Quarter Financial & Operating Results on January 21, 2026
GURUGRAM, India & NEW YORK–(BUSINESS WIRE)–$MMYT #Financialresults–MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal 2026 third... Read more.
Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands
Cellares’ new IDMO Smart Factory in Leiden, Netherlands, expands commercial-scale manufacturing capacity for European cell therapy patient populations through... Read more.